Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GEMI | SBET |
|---|---|---|
| Price | $4.49 | $8.95 |
| Change today | ▼ 3.85% | ▼ 5.79% |
| Market cap | $582.14M | $1.94B |
| Return, 3 months | +5.6% | +68.2% |
| Return, year to date | -54.7% | +0.1% |
| Return, 1 year | -82.5% | -49.1% |
| P/E (TTM) | -1.1 | -2.0 |
| P/B | 1.2 | 1.4 |
| P/E percentile vs own 5y | 58th | 11th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +36.6% | +1,553.9% |
| Net profit growth (YoY) | +19.1% | -281.2% |
| Gross margin | -70.3% | 97.0% |
| Operating margin | -195.1% | -18.4% |
| Net margin | -250.1% | -3,406.3% |
| Return on equity | – | -183.6% |
| Analyst target vs. price | +15.6% | +97.4% |
| Analyst buy share | 33% | 100% |
| RSI (14) | 43 | 50 |
| 30-day volatility | 114.6% | 80.6% |
| Max drawdown, 1 year | -86.2% | -76.3% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
